Literature DB >> 21613819

Systemic Par-4 inhibits non-autochthonous tumor growth.

Yanming Zhao1, Ravshan Burikhanov, Jason Brandon, Shirley Qiu, Brent J Shelton, Brett Spear, Subbarao Bondada, Scott Bryson, Vivek M Rangnekar.   

Abstract

The tumor suppressor protein Par-4 (Prostate apoptosis response-4) is spontaneously secreted by normal and cancer cells. Extracellular Par-4 induces caspase-dependent apoptosis in cancer cell cultures by binding, via its effector SAC domain, to cell surface GRP78 receptor. However, the functional significance of extracellular Par-4/SAC has not been validated in animal models. We show that Par-4/SAC-transgenic mice express systemic Par-4/SAC protein and are resistant to the growth of non-autochthonous tumors. Consistently, secretory Par-4/SAC pro-apoptotic activity can be transferred from these cancer-resistant transgenic mice to cancer-susceptible mice by bone marrow transplantation. Moreover, intravenous injection of recombinant Par-4 or SAC protein inhibits metastasis of cancer cells. Collectively, our findings indicate that extracellular Par-4/SAC is systemically functional in inhibition of tumor growth and metastasis progression, and may merit investigation as a therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613819      PMCID: PMC3154287          DOI: 10.4161/cbt.12.2.15734

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  12 in total

1.  Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.

Authors:  J Cook; S Krishnan; S Ananth; S F Sells; Y Shi; M M Walther; W M Linehan; V P Sukhatme; M H Weinstein; V M Rangnekar
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

Review 2.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

3.  Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.

Authors:  Gema Moreno-Bueno; Pablo J Fernandez-Marcos; Manuel Collado; Mercedes J Tendero; Socorro M Rodriguez-Pinilla; Isabel Garcia-Cao; David Hardisson; Maria T Diaz-Meco; Jorge Moscat; Manuel Serrano; Jose Palacios
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

4.  Tumour-suppression activity of the proapoptotic regulator Par4.

Authors:  Isabel García-Cao; Angeles Duran; Manuel Collado; Maria J Carrascosa; Juan Martín-Caballero; Juana M Flores; Maria T Diaz-Meco; Jorge Moscat; Manuel Serrano
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

5.  Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells.

Authors:  Nadia El-Guendy; Yanming Zhao; Sushma Gurumurthy; Ravshan Burikhanov; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.

Authors:  S F Sells; D P Wood; S S Joshi-Barve; S Muthukumar; R J Jacob; S A Crist; S Humphreys; V M Rangnekar
Journal:  Cell Growth Differ       Date:  1994-04

7.  Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Natl Cancer Inst       Date:  2009-06-09       Impact factor: 13.506

8.  Cancer resistance in transgenic mice expressing the SAC module of Par-4.

Authors:  Yanming Zhao; Ravshan Burikhanov; Shirley Qiu; Subodh M Lele; C Darrell Jennings; Subbarao Bondada; Brett Spear; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 9.  Apoptosis by Par-4 in cancer and neurodegenerative diseases.

Authors:  Nadia El-Guendy; Vivek M Rangnekar
Journal:  Exp Cell Res       Date:  2003-02-01       Impact factor: 3.905

10.  Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.

Authors:  P Eschwège; S Moutereau; S Droupy; R Douard; J-L Gala; G Benoit; M Conti; P Manivet; S Loric
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  14 in total

1.  Fbxo45 joins the 'Par-4'ty in controlling apoptosis of cancer cells.

Authors:  Z Wang; W Wei
Journal:  Cell Death Differ       Date:  2014-10       Impact factor: 15.828

2.  A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Authors:  Nikhil Hebbar; Ravshan Burikhanov; Nidhi Shukla; Shirley Qiu; Yanming Zhao; Kojo S J Elenitoba-Johnson; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2017-06-16       Impact factor: 12.701

3.  Paracrine apoptotic effect of p53 mediated by tumor suppressor Par-4.

Authors:  Ravshan Burikhanov; Tripti Shrestha-Bhattarai; Nikhil Hebbar; Shirley Qiu; Yanming Zhao; Gerard P Zambetti; Vivek M Rangnekar
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

Review 4.  Mechanisms of apoptosis by the tumor suppressor Par-4.

Authors:  Nikhil Hebbar; Chi Wang; Vivek M Rangnekar
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

5.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

6.  Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Authors:  Ravshan Burikhanov; Tripti Shrestha-Bhattarai; Shirley Qiu; Nidhi Shukla; Nikhil Hebbar; Subodh M Lele; Craig Horbinski; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

7.  Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.

Authors:  Kyungbo Kim; Pereira Araujo; Nikhil Hebbar; Ziyuan Zhou; Xirong Zheng; Fang Zheng; Vivek M Rangnekar; Chang-Guo Zhan
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

8.  Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.

Authors:  A de Thonel; A Hazoumé; V Kochin; K Isoniemi; G Jego; E Fourmaux; A Hammann; H Mjahed; O Filhol; O Micheau; P Rocchi; V Mezger; J E Eriksson; V M Rangnekar; C Garrido
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

9.  Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.

Authors:  Shayan Sarkar; Sumeet Jain; Vineeta Rai; Dipak K Sahoo; Sumita Raha; Sujit Suklabaidya; Shantibhusan Senapati; Vivek M Rangnekar; Indu B Maiti; Nrisingha Dey
Journal:  Front Plant Sci       Date:  2015-10-07       Impact factor: 5.753

10.  Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells.

Authors:  Michelly C Pereira; Simone A de Bessa-Garcia; Ravshan Burikhanov; Ana Carolina Pavanelli; Lourival Antunes; Vivek M Rangnekar; Maria A Nagai
Journal:  Int J Oncol       Date:  2013-06-12       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.